Liquid Biopsy Market 2021 By Industry Share, Key Findings, Company Profiles, Growth Strategy, Developing Technologies, Demand, Investment Opportunities and Forecast by Regions till 2030

In a recent published report, Kenneth Research has updated the market report for Liquid Biopsy Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Liquid Biopsy Market products.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10163645

Kenneth Research has recently added a report titled Liquid Biopsy Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.

According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

According to Azoth Analytics research report, the Liquid Biopsy was valued at USD 899.55 million for the year 2018.

Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market.

Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: 
https://www.kennethresearch.com/sample-request-10163645

In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third party payers, hindering the market growth.

Scope of the Report

Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Regional Liquid Biopsy Markets – North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Country Analysis – U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)
• Liquid Biopsy Market: Size, Growth, Forecast
• Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
• Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
• Analysis By Product Type: Reagents, Instruments

Request For Full Report: https://www.kennethresearch.com/sample-request-10163645

Company Analysis – Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen.

Other Report Highlights
• Competitive Landscape – Sales, Segments, Market Share, Business Strategies
• Investment and Partnerships
• Product Analysis
• Market Dynamics – Drivers and Restraints.
• Market Trends
• Porter Five Forces Analysis.
• SWOT Analysis.

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:  Sales@kennethresearch.com

Leave a Reply